Table 5. Results on cell viability and proliferation after DEX treatment on primary chondrocytes in non-arthritic model systems.

− denotes a decrease and = no change from control.

Authors	Year	Cell type	DEX dose	Duration	Effect on viability
Shen et al.	2015	Human	1 μM, 10 μM	24 h	−
Liu et al.	2014	Human	100 μM	72 h	−
Stueber et al.	2014	Human	10 μM–1 mM	1 h	=
Zaman et al.	2014	Human	1 μM	24–72 h	−
Song et al.	2012	Human	20–200 μM	24 h-1 week	−
Dragoo et al.	2012	Human	1.5 mM	1 week	=
Authors	Year	Cell type	DEX dose	Duration	Effect on proliferation
Mushtaq et al.	2002	Mouse	10 nM–1 μM	20 d	−
Miyazaki et al.	2000	Rat	0.1 nM–100 μM	36 h	−
Hainque et al.	1987	Rabbit	10 nM–100 μM	24 h-2 weeks	−
Maor and Silbermann	1986	Mouse	1 μM	24 h	−